While tumor PD-L1 expression is a key biomarker for ICI response, PD-L1 expressed by glial cells may independently suppress T-cell activation and contribute to CNS immune escape, regardless of antibody availability or tumor expression levels [33]. Here, CD274 is linked to neoplasm.